{"entity":{"type":"insider","cik":"0001439174","url":"/insider/0001439174","json_url":"/insider/0001439174.json","name":"Sheridan William P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":15,"first":"2009-02-03","last":"2022-03-14","span_basis":"filed_date"},"name_variants":[{"name":"Sheridan William P","source":"filing","n_filings":15,"first_seen":"2009-02-03","last_seen":"2022-03-14"}],"transactions":[{"id":6599303,"accession":"0001127602-22-009124","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-22-009124","line_url":"/filing/0001127602-22-009124","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161139.0,"shares_display":"161,139","price_per_share":16.87668987644208,"price_display":"16.88","price_state":"stated","total_value":2719492.93,"total_display":"2,719,492.93","total_whole":"2,719,493","shares_owned_after":39354.0,"shares_owned_after_display":"39,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-10","filed_date":"2022-03-14","scope":"insider","n_lines":2},{"id":4292050,"accession":"0001127602-21-018509","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001127602-21-018509","line_url":"/filing/0001127602-21-018509#line-8","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91814.0,"shares_display":"91,814","price_per_share":15.02,"price_display":"15.02","price_state":"stated","total_value":1379046.28,"total_display":"1,379,046.28","total_whole":"1,379,046","shares_owned_after":14475.0,"shares_owned_after_display":"14,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-06-01","scope":"insider"},{"id":4292032,"accession":"0001127602-21-018509","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-21-018509","line_url":"/filing/0001127602-21-018509#line-4","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71759.0,"shares_display":"71,759","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1076385.0,"total_display":"1,076,385.00","total_whole":"1,076,385","shares_owned_after":14475.0,"shares_owned_after_display":"14,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-06-01","scope":"insider"},{"id":4516346,"accession":"0001127602-21-007642","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-007642","line_url":"/filing/0001127602-21-007642#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Senior VP - CMO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41250.0,"shares_display":"41,250","price_per_share":11.57,"price_display":"11.57","price_state":"stated","total_value":477262.5,"total_display":"477,262.50","total_whole":"477,263","shares_owned_after":11475.0,"shares_owned_after_display":"11,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-22","filed_date":"2021-02-24","scope":"insider"},{"id":6527671,"accession":"0001127602-18-036977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-18-036977","line_url":"/filing/0001127602-18-036977#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Senior VP - CMO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20488.0,"shares_display":"20,488","price_per_share":7.58,"price_display":"7.58","price_state":"stated","total_value":155299.04,"total_display":"155,299.04","total_whole":"155,299","shares_owned_after":2725.0,"shares_owned_after_display":"2,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2018-12-20","scope":"insider"},{"id":6483835,"accession":"0001127602-18-025155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-025155","line_url":"/filing/0001127602-18-025155#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Senior VP - CMO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62500.0,"shares_display":"62,500","price_per_share":7.03,"price_display":"7.03","price_state":"stated","total_value":439375.0,"total_display":"439,375.00","total_whole":"439,375","shares_owned_after":23213.0,"shares_owned_after_display":"23,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-09","filed_date":"2018-08-13","scope":"insider"},{"id":6386648,"accession":"0001127602-18-019981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-019981","line_url":"/filing/0001127602-18-019981#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Senior VP - CMO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42112.0,"shares_display":"42,112","price_per_share":6.3,"price_display":"6.30","price_state":"stated","total_value":265305.6,"total_display":"265,305.60","total_whole":"265,306","shares_owned_after":21058.0,"shares_owned_after_display":"21,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-05","scope":"insider"},{"id":4893777,"accession":"0001127602-17-032183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-032183","line_url":"/filing/0001127602-17-032183#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Senior VP - CMO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64310.0,"shares_display":"64,310","price_per_share":4.72,"price_display":"4.72","price_state":"stated","total_value":303543.2,"total_display":"303,543.20","total_whole":"303,543","shares_owned_after":23855.0,"shares_owned_after_display":"23,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-11-15","scope":"insider"},{"id":8749410,"accession":"0001127602-15-021143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-021143","line_url":"/filing/0001127602-15-021143#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Senior VP - CMO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70389.0,"shares_display":"70,389","price_per_share":15.05,"price_display":"15.05","price_state":"stated","total_value":1059354.45,"total_display":"1,059,354.45","total_whole":"1,059,354","shares_owned_after":95123.0,"shares_owned_after_display":"95,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-19","filed_date":"2015-06-22","scope":"insider"},{"id":6191341,"accession":"0001127602-14-036193","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-14-036193","line_url":"/filing/0001127602-14-036193#line-6","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Senior VP - CMO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23104.0,"shares_display":"23,104","price_per_share":12.06,"price_display":"12.06","price_state":"stated","total_value":278634.24,"total_display":"278,634.24","total_whole":"278,634","shares_owned_after":92518.0,"shares_owned_after_display":"92,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-30","filed_date":"2014-12-31","scope":"insider"},{"id":6191335,"accession":"0001127602-14-036193","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-14-036193","line_url":"/filing/0001127602-14-036193#line-4","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (Senior VP - CMO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105295.0,"shares_display":"105,295","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":1308816.85,"total_display":"1,308,816.85","total_whole":"1,308,817","shares_owned_after":92518.0,"shares_owned_after_display":"92,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-31","scope":"insider"},{"id":2626852,"accession":"0001127602-12-009525","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-009525","line_url":"/filing/0001127602-12-009525#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (SR VP - CMO)","role_mark":"O","role_mark_label":"Officer (SR VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":956.0,"shares_display":"956","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":4569.68,"total_display":"4,569.68","total_whole":"4,570","shares_owned_after":29330.0,"shares_owned_after_display":"29,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-02","filed_date":"2012-03-05","scope":"insider"},{"id":7462178,"accession":"0001127602-10-010915","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-10-010915","line_url":"/filing/0001127602-10-010915#line-3","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (SR VP - CMO)","role_mark":"O","role_mark_label":"Officer (SR VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18593.0,"shares_display":"18,593","price_per_share":8.006,"price_display":"8.01","price_state":"stated","total_value":148855.558,"total_display":"148,855.56","total_whole":"148,856","shares_owned_after":1664.0,"shares_owned_after_display":"1,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-08","filed_date":"2010-04-12","scope":"insider"},{"id":7236691,"accession":"0001127602-10-001458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-001458","line_url":"/filing/0001127602-10-001458#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (SR VP - CMO)","role_mark":"O","role_mark_label":"Officer (SR VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4166.0,"shares_display":"4,166","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":33536.3,"total_display":"33,536.30","total_whole":"33,536","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":5587833,"accession":"0001127602-09-024109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-09-024109","line_url":"/filing/0001127602-09-024109#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (SR VP - CMO)","role_mark":"O","role_mark_label":"Officer (SR VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4167.0,"shares_display":"4,167","price_per_share":8.17,"price_display":"8.17","price_state":"stated","total_value":34044.39,"total_display":"34,044.39","total_whole":"34,044","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-01","filed_date":"2009-12-02","scope":"insider"},{"id":5795828,"accession":"0001127602-09-020733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-09-020733","line_url":"/filing/0001127602-09-020733#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (SR VP - CMO)","role_mark":"O","role_mark_label":"Officer (SR VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP - CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":8.9234,"price_display":"8.92","price_state":"stated","total_value":53540.4,"total_display":"53,540.40","total_whole":"53,540","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-14","filed_date":"2009-10-15","scope":"insider"},{"id":5735751,"accession":"0001127602-09-002355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-09-002355","line_url":"/filing/0001127602-09-002355#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001439174","owner_name":"Sheridan William P","owner_display_name":"Sheridan William P","owner_url":"/insider/0001439174","role":"Officer (SR VP - CMO)","role_mark":"O","role_mark_label":"Officer (SR VP - CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP - CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.615,"price_display":"1.62","price_state":"stated","total_value":4845.0,"total_display":"4,845.00","total_whole":"4,845","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-30","filed_date":"2009-02-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Officer (Chief Medical Officer)","n_filings":15,"first_seen":"2009-02-03","last_seen":"2022-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001439174","retrieved_at":"2026-08-22T16:25:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}